Clinical Trial Update: Safety and Efficacy Study of Intramyocardial Stem Cell Therapy in Patients With Dilated Cardiomyopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating intramyocardial stem cell therapy in patients with dilated cardiomyopathy has completed, assessing safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Dilated Cardiomyopathy, Chronic Heart Failure | Phase 2 | Status: COMPLETED